Plain-English translation of NCT07243561 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1/2 โ A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is a 24-week study testing a nasal spray called hUC-MSC-EXOs (made from stem cells found in umbilical cord tissue) to see if it can safely help improve the core symptoms of autism in children between ages 3 and 7. Some children will receive the medication three times a week, while others will be in a comparison group that doesn't receive the treatment. Both groups will be closely watched to see how safe and effective this treatment is.
Standard behavioral therapy helps many children with autism, but some children don't improve enough even after months of treatment. This study is exploring whether this new nasal spray medication could offer additional help for those children who haven't responded well to current approaches.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If your child is in the treatment group, you would bring them to the clinic on Mondays, Wednesdays, and Fridays for a nasal spray application โ a total of 10 treatments over the 24-week study period. Both the treatment group and the control group (which doesn't receive the spray) will have regular check-ups and assessments to monitor your child's symptoms, safety, and any changes over time. The entire study lasts 6 months.
AI-generated summary from trial data ยท Aug 29, 2026 ยท Not medical advice
China